Advertisement

Topics

Shire submits marketing application for lifitegrast to treat dry eye disease in Europe

19:00 EDT 16 Aug 2017 | Pharmaceutical Technology

Shire has filed marketing authorisation application (MAA) for lifitegrast as a treatment for patients with dry eye disease in Europe.

Original Article: Shire submits marketing application for lifitegrast to treat dry eye disease in Europe

NEXT ARTICLE

More From BioPortfolio on "Shire submits marketing application for lifitegrast to treat dry eye disease in Europe"

Advertisement
Quick Search
Advertisement
Advertisement